Evidence map›Paper›PMID 31471729›Full record

Trial reportJournal of general internal medicine2019

Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial.

Tannaz Moin, O Kenrik Duru, Norman Turk, Janet S Chon, Dominick L Frosch, Jacqueline M Martin, Kia Skrine Jeffers, Yelba Castellon-Lopez, Chi-Hong Tseng, Keith Norris and 1 more

Registry-linked trialOpen access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of general internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02384109 (A Pharmacist-Coordinated Implementation of the Diabetes Prevention Program), which is not on this map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
11.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02384109 nacompletednot on this map

A Pharmacist-Coordinated Implementation of the Diabetes Prevention Program

TypeinterventionalSponsorUniversity of California, Los AngelesRan2015 to 2019Enrolled521ConditionsPrediabetic StateArmsShared decision-making with pharmacists, Standard care from primary care providers
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Perceived Penalties for Sharing Patient Beliefs with Health Care Providers.Medical decision making : an international journal of the Society for Medical Decision Making · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Tannaz MoinDavid Geffen School of Medicine, University of California, Glendon Ave Suite, Los Angeles, CA, USA. tmoin@mednet.ucla.edu.
O Kenrik DuruDavid Geffen School of Medicine, University of California, Glendon Ave Suite, Los Angeles, CA, USA.
Norman TurkDavid Geffen School of Medicine, University of California, Glendon Ave Suite, Los Angeles, CA, USA.
Janet S ChonDavid Geffen School of Medicine, University of California, Glendon Ave Suite, Los Angeles, CA, USA.
Dominick L FroschPalo Alto Medical Foundation Research Institute, Palo Alto, CA, USA.
Jacqueline M MartinDavid Geffen School of Medicine, University of California, Glendon Ave Suite, Los Angeles, CA, USA.
Kia Skrine JeffersDavid Geffen School of Medicine, University of California, Glendon Ave Suite, Los Angeles, CA, USA.
Yelba Castellon-LopezDavid Geffen School of Medicine, University of California, Glendon Ave Suite, Los Angeles, CA, USA.
Chi-Hong TsengDavid Geffen School of Medicine, University of California, Glendon Ave Suite, Los Angeles, CA, USA.
Keith NorrisDavid Geffen School of Medicine, University of California, Glendon Ave Suite, Los Angeles, CA, USA.
Carol M MangioneDavid Geffen School of Medicine, University of California, Glendon Ave Suite, Los Angeles, CA, USA.
Palo Alto Institute · USUniversity of California, Los Angeles · US

Funding

NCATS NIH HHS UL1 TR000124NIA NIH HHS K08 AG033630
6 · The paper itself

Abstract

importanceIntensive lifestyle change (e.g., the Diabetes Prevention Program) and metformin reduce type 2 diabetes risk among patients with prediabetes. However, real-world uptake remains low. Shared decision-making (SDM) may increase awareness and help patients select and follow through with informed options for diabetes prevention that are aligned with their preferences.

objectiveTo test the effectiveness of a prediabetes SDM intervention.

designCluster randomized controlled trial.

settingTwenty primary care clinics within a large regional health system.

participantsOverweight/obese adults with prediabetes (BMI ≥ 24 kg/m

interventionIntervention clinic patients were invited to participate in a face-to-face SDM visit with a pharmacist who used a decision aid (DA) to describe prediabetes and four possible options for diabetes prevention: DPP, DPP ± metformin, metformin only, or usual care. MAIN OUTCOMES AND MEASURES: Primary endpoint was uptake of DPP (≥ 9 sessions), metformin, or both strategies at 4 months. Secondary endpoint was weight change (lbs.) at 12 months.

resultsUptake of DPP and/or metformin was higher among SDM participants (n = 351) than controls receiving usual care (n = 1028; 38% vs. 2%, p < .001). At 12-month follow-up, adjusted weight loss (lbs.) was greater among SDM participants than controls (- 5.3 vs. - 0.2, p < .001). LIMITATIONS: Absence of DPP supplier participation data for matched patients in usual care clinics. CONCLUSIONS AND RELEVANCE: A prediabetes SDM intervention led by pharmacists increased patient engagement in evidence-based options for diabetes prevention and was associated with significantly greater uptake of DPP and/or metformin at 4 months and weight loss at 12 months. Prediabetes SDM may be a promising approach to enhance prevention efforts among patients at increased risk.

trial registrationThis study was registered at clinicaltrails.gov (NCT02384109)).

Indexed as

Risk Reduction BehaviorAdultAgedDecision Making, SharedDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsMaleMetforminMiddle AgedObesityPharmacistsPrediabetic StateWeight LossHypoglycemic AgentsMetformindiabetes mellitusshared decision-making

Identifiers

PMID31471729
PMCPMC6848409
OpenAlexW2970632162

What Socratic holds

Texttitle and abstract
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.